PHAR

Pharming Group (PHAR)

About Pharming Group (PHAR)

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.

Details

Daily high

$13.09

Daily low

$12.67

Price at open

$12.73

52 Week High

$21.34

52 Week Low

$8.69

Market cap

916.7M

Dividend yield

0.00%

Volume

19,569

Avg. volume

13,432

P/E ratio

72.96

Pharming Group News